Condition

Central Retinal Vein Occlusion (1)

Hemiretinal Vein Occlusion (1)

Macular Edema (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Hoffmann-La Roche (1)

Collaborator

Chugai Pharmaceutical (1)

Intervention

aflibercept (1)

faricimab (1)

sham procedure (1)

Study Documents

Intervention Type

drug (1)

procedure (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

hemiretinal vein occlusion

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Macular Edema, Central Retinal Vein Occlusion, Hemiretinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham

Active, not recruiting

Macular Edema
+2 more

Faricimab
+2 more

Mesa, Arizona
+193 more

Jul 25, 2022